EUVIMEDEUVIMED entdecken
Open Access

The histone methyltransferase MLL1/KMT2A in monocytes drives coronavirus-associated coagulopathy and inflammation

Sriganesh B Sharma iD, William J Melvin iD, Christopher O Audu iD, Monica Bame, Nicole Rhoads iD, Weisheng Wu, Yogendra Kanthi, Jason S Knight iD, Reheman Adili iD, Michael A Holinstat iD, Thomas W Wakefield, Peter K Henke und 3 weitere

Blood · 2023

DOI: 10.1182/blood.2022015917 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, 2023. Verfasst von Sriganesh B Sharma und 14 weiteren Autor:innen. Beteiligte Einrichtung: Section of General Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI. Hauptthemen laut MEDLINE: COVID-19, Histone-Lysine N-Methyltransferase. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus-associated coagulopathy (CAC) is a morbid and lethal sequela of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. CAC results from a perturbed balance between coagulation and fibrinolysis and occurs in conjunction with exaggerated activation of monocytes/macrophages (MO/Mφs), and the mechanisms that collectively govern this phenotype seen in CAC remain unclear. Here, using experimental models that use the murine betacoronavirus MHVA59, a well-established model of SARS-CoV-2 infection, we identify that the histone methyltransferase mixed lineage leukemia 1 (MLL1/KMT2A) is an important regulator of MO/Mφ expression of procoagulant and profibrinolytic factors such as tissue factor (F3; TF), urokinase (PLAU), and urokinase receptor (PLAUR) (herein, “coagulopathy-related factors”) in noninfected and infected cells. We show that MLL1 concurrently promotes the expression of the proinflammatory cytokines while suppressing the expression of interferon alfa (IFN-α), a well-known inducer of TF and PLAUR. Using in vitro models, we identify MLL1-dependent NF-κB/RelA–mediated transcription of these coagulation-related factors and identify a context-dependent, MLL1-independent role for RelA in the expression of these factors in vivo. As functional correlates for these findings, we demonstrate that the inflammatory, procoagulant, and profibrinolytic phenotypes seen in vivo after coronavirus infection were MLL1-dependent despite blunted Ifna induction in MO/Mφs. Finally, in an analysis of SARS-CoV-2 positive human samples, we identify differential upregulation of MLL1 and coagulopathy-related factor expression and activity in CD14+ MO/Mφs relative to noninfected and healthy controls. We also observed elevated plasma PLAU and TF activity in COVID-positive samples. Collectively, these findings highlight an important role for MO/Mφ MLL1 in promoting CAC and inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Histone-Lysine N-MethyltransferaseAnimalsHumansMiceHistonesInflammationMonocytesMyeloid-Lymphoid Leukemia ProteinSARS-CoV-2Urokinase-Type Plasminogen Activator

Substanzen

Histone-Lysine N-MethyltransferaseHistonesMyeloid-Lymphoid Leukemia ProteinUrokinase-Type Plasminogen ActivatorKMT2A protein, human

Autor:innen und Institutionen

  • Section of General Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.
  • Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.
  • Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI.
  • Department of Pharmacology, University of Michigan, Ann Arbor, MI.
  • Bioinformatics Core, Biomedical Research Core Facilities, University of Michigan, Ann Arbor, MI.
  • Laboratory of Vascular Thrombosis & Inflammation, National Heart, Lung, and Blood Institute, Bethesda, MD.

ORCID-Profile: Sriganesh B Sharma, William J Melvin, Christopher O Audu, Nicole Rhoads, Jason S Knight, Reheman Adili, Michael A Holinstat, Bethany B Moore, Katherine A Gallagher, Andrea T Obi

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • NHLBI NIH HHS
  • Intramural NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Sharma, S. B., Melvin, W. J., Audu, C. O., Bame, M., Rhoads, N., Wu, W., Kanthi, Y., Knight, J. S., Adili, R., Holinstat, M. A., Wakefield, T. W., Henke, P. K., Moore, B. B., Gallagher, K. A., & Obi, A. T. (2023). The histone methyltransferase MLL1/KMT2A in monocytes drives coronavirus-associated coagulopathy and inflammation. Blood. https://doi.org/10.1182/blood.2022015917

Vancouver

Sharma SB, Melvin WJ, Audu CO, Bame M, Rhoads N, Wu W, et al. The histone methyltransferase MLL1/KMT2A in monocytes drives coronavirus-associated coagulopathy and inflammation. Blood. 2023. doi:10.1182/blood.2022015917

BibTeX
@article{Sharma2023,
  author = {Sharma, Sriganesh B and Melvin, William J and Audu, Christopher O and Bame, Monica and Rhoads, Nicole and Wu, Weisheng and Kanthi, Yogendra and Knight, Jason S and Adili, Reheman and Holinstat, Michael A and Wakefield, Thomas W and Henke, Peter K and Moore, Bethany B and Gallagher, Katherine A and Obi, Andrea T},
  title = {The histone methyltransferase MLL1/KMT2A in monocytes drives coronavirus-associated coagulopathy and inflammation},
  journal = {Blood},
  year = {2023},
  doi = {10.1182/blood.2022015917}
}
Kostenlos starten →